3 Equity REIT Stocks Worth Betting on Despite Industry Headwinds

The REIT and Equity Trust-Other group faces higher-for-longer rates, elevated bond yields and construction costs, with 2026 and 2027 aggregate FFO estimates revised down 0.8% and 7.4%, respectively; the industry gained 6.3% over the past year versus 15.2% for the S&P 500. Despite these headwinds, Zacks highlights American Healthcare REIT, Terreno Realty and RLJ Lodging Trust, citing AHR's 13.2% same-store NOI growth and $2.0B of investments, TRNO's 97.6% occupancy and 27.7% cash-rent growth, and RLJ's 6.8% RevPAR growth. The sector trades at 15.61x forward P/FFO, below its 15.82x five-year median, but its Zacks industry rank of 156 out of 247 signals weak near-term prospects.

Analysis

The investable signal is dispersion, not a broad REIT-beta recovery. AHR and TRNO have asset-level pricing power and balance-sheet capacity to convert sector-wide capital scarcity into accretive share gains; weaker private owners face refinancing constraints and are more likely sellers. That dynamic should widen the valuation gap over the next 6-18 months, particularly in senior housing and coastal infill industrial, where replacement cost and permitting constraints limit competitive supply.

AHR's operating exposure creates the highest earnings torque but also makes it less bond-like than traditional healthcare landlords: labor-cost reacceleration or a slowdown in senior-housing occupancy would transmit quickly to NOI. TRNO's leasing spreads are more durable, but its premium-quality industrial profile leaves it more vulnerable to multiple compression if the 10-year Treasury rises; a 50 bp yield move can overwhelm a single quarter of rent growth in the near term. The key 1-3 month catalysts are leasing spreads, same-store NOI and acquisition cap rates rather than generic sector estimate revisions.

RLJ is the least attractive fresh entry after its sharp rerating. Hotel cash flows reset daily, so it has upside in a benign growth environment, but its urban/business-transient exposure makes it the first of the three to absorb a corporate-travel pullback; renovation and conversion returns remain management claims until they appear in RevPAR index and margin data. Consensus may be underestimating the structural benefit of constrained new supply, but overestimating how quickly lower rates alone restore REIT multiples: credit spreads, not just policy rates, determine external-growth economics.

Key Decisions for Investors

• Initiate a 6-12 month long AHR / short VTR pair, sized beta-neutral. AHR offers operating-NOI and acquisition upside while VTR has greater exposure to more mature healthcare asset cash flows; target 15-20% relative return. Exit if AHR's SHOP occupancy or same-store NOI misses guidance for two consecutive quarters, or net debt/EBITDA moves above 3.5x.
• Accumulate TRNO on Treasury-yield-driven weakness rather than chase momentum; use a 5-7% pullback or a 10-year yield spike above the recent range as entry triggers. Target a 12-18 month 15% total return from embedded rent resets and scarce infill supply; stop if occupancy falls below 95% or new/renewal cash leasing spreads turn negative.
• Do not add directional RLJ at current levels. Maintain only through a hedged long RLJ / short XHB or IYR structure if monthly RevPAR and business-transient trends remain positive; a 2-3 month RevPAR deceleration or weaker group-booking commentary should trigger a short bias, given elevated cyclicality after the rally.
• Monitor unsecured REIT debt spreads and acquisition cap rates as the gating data for the thesis. A sustained widening in BBB REIT spreads or cap-rate expansion faster than rent growth would make externally funded acquisition assumptions non-accretive and warrants reducing AHR and TRNO exposure.